Undervalued Small-Cap Stocks on NAS March 2026

March 26, 2026

Small, Micro and Nano-Cap

Stocks in the Small, Micro and Nano Market Cap groups have a market capitalization of less than $2 billion.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued stocks on the NAS

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
NMRA Neumora Therapeutics, Inc 2.09 9.76 7.67 (367.0%) 977381 337.4 0.0 0.0
XRX Xerox Corp 2.48 8.52 6.04 (243.4%) 3416454 310.5 14.1 -0.2
RXST Rxsight Inc 10.79 33.81 23.02 (213.3%) 749550 437.1 0.0 -6.9
AVXL Anavex Life Sciences Corp 3.80 11.04 7.24 (190.5%) 2720451 323.3 0.0 -6.0
HELE Helen of Troy Ltd 21.00 60.82 39.82 (189.6%) 728865 484.4 0.0 0.0
ULH Universal Logistics Holdi 15.18 43.63 28.45 (187.4%) 59531 399.9 2.0 -5.6
SPT Sprout Social Inc 11.40 31.12 19.72 (173.0%) 1001046 660.0 0.0 -7.6
CCOI Cogent Communications Gro 21.86 58.43 36.57 (167.3%) 1377384 1042.2 11.3 -4.8
SABR Sabre Corporation 1.34 3.56 2.22 (166.0%) 5863702 610.0 0.0 1.1
RCKT Rocket Pharmaceuticals In 3.42 8.96 5.54 (162.1%) 2029973 376.5 0.0 -2.3
All data provided as at market close December 14, 2025.

Company Details

Neumora Therapeutics, Inc

NMRA:NAS

Close Price

2.09

Our Valuation

9.76

% Difference

366.99

Market Cap ($M)

337

P/E Ratio

0.0

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder.

Access the stockcalc valuation


Xerox Corp

XRX:NAS

Close Price

2.48

Our Valuation

8.52

% Difference

243.41

Market Cap ($M)

310

P/E Ratio

-0.2

Xerox Holdings Corporation, together with its subsidiaries, operates as a workplace technology company that integrates hardware, services, and software for enterprises in North America, Latin America, Europe, the Middle East, Africa, India, and internationally. It operates in two segments: Print and Other, and Xerox Financial Services (XFS).

Access the stockcalc valuation


Rxsight Inc

RXST:NAS

Close Price

10.79

Our Valuation

33.81

% Difference

213.35

Market Cap ($M)

437

P/E Ratio

-6.9

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.

Access the stockcalc valuation


Anavex Life Sciences Corp

AVXL:NAS

Close Price

3.80

Our Valuation

11.04

% Difference

190.53

Market Cap ($M)

323

P/E Ratio

-6.0

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer .

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Helen of Troy Ltd

HELE:NAS

Close Price

21.00

Our Valuation

60.82

% Difference

189.60

Market Cap ($M)

484

P/E Ratio

0.0

Helen of Troy Limited provides various consumer products in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates in two segments: Home & Outdoor and Beauty & Wellness.

Access the stockcalc valuation


Universal Logistics Holdi

ULH:NAS

Close Price

15.18

Our Valuation

43.63

% Difference

187.40

Market Cap ($M)

400

P/E Ratio

-5.6

Universal Logistics Holdings, Inc. provides customized transportation and logistics solutions in the United States, Mexico, Canada, and Colombia. It operates through three segments: Contract Logistics, Intermodal, and Trucking.

Access the stockcalc valuation


Sprout Social Inc

SPT:NAS

Close Price

11.40

Our Valuation

31.12

% Difference

172.98

Market Cap ($M)

660

P/E Ratio

-7.6

Sprout Social, Inc. designs, develops, and operates a web-based social media management platform in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides cloud software for social messaging, data and workflows in a unified system of record, intelligence, and action.

Access the stockcalc valuation


Cogent Communications Gro

CCOI:NAS

Close Price

21.86

Our Valuation

58.43

% Difference

167.28

Market Cap ($M)

1042

P/E Ratio

-4.8

Cogent Communications Holdings, Inc., through its subsidiaries, provides high-speed Internet access, private network, and data center colocation space services in North America, South America, Europe, Oceania, and Africa.

Access the stockcalc valuation


Sabre Corporation

SABR:NAS

Close Price

1.34

Our Valuation

3.56

% Difference

166.03

Market Cap ($M)

610

P/E Ratio

1.1

Sabre Corporation, together with its subsidiaries, operates as a software and technology company for travel industry in the United States, Europe, Asia-Pacific, and internationally. It operates in two segments, Travel Solutions and Hospitality Solutions.

Access the stockcalc valuation


Rocket Pharmaceuticals In

RCKT:NAS

Close Price

3.42

Our Valuation

8.96

% Difference

162.11

Market Cap ($M)

377

P/E Ratio

-2.3

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Neumora Therapeutics, and Xerox are the most undervalued Small-Cap stocks on the NAS. See which other companies made the Small-Cap list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-march-2026
Neumora Therapeutics, $NMRA and Xerox $XRX are the most undervalued Small-Cap stocks on the #NAS. See the full list of Small-Cap stocks here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-march-2026
Neumora Therapeutics, and Xerox are the most undervalued Small-Cap stocks on the NAS. See which other companies made the Small-Cap list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-nas-march-2026

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.